FDA Adverse Event Injury Summary report: N

PERITONEAL CATHETER

MDR report key: 11847859 · Received May 19, 2021

Report

Report Number
3009211636-2021-00111
Event Type
Injury
Date Received
May 19, 2021
Date of Event
October 15, 2020
Report Date
May 19, 2021
Manufacturer
COVIDIEN MFG SOLUTIONS S.A.
Product Code
FJS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

TITLE: RISK FACTORS FOR PERITONEAL DIALYSIS WITHDRAWAL DUE TO PERITONEAL DIALYSIS-RELATED PERITONITIS SOURCE: NE´PHROLOGIE & THE´RAPEUTIQUE 17 (2021) 108¿113 ACCEPTED 15 OCTOBER 2020. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

ACCORDING TO THE LITERATURE SOURCE OF STUDY, THIS RETROSPECTIVE ANALYSIS EVALUATED CLINICAL CHARACTERISTICS, LABORATORY DATA, AND CAUSATIVE MICROORGANISMS OF 204 EPISODES OF PERITONEAL DIALYSIS-RELATED PERITONITIS BETWEEN 2007 AND 2018. OF THESE, 38 CASES WITHDREW FROM PD (PERITONEAL DIALYSIS) DUE TO PERITONITIS. ALL CASES UNDERWENT PD WITH A DOUBLE-CUFFEDAND STRAIGHT CATHETER. THE DIALYSATE CULTURE SHOWED THAT STAPHYLOCOCCUS SPECIES WERE THE MOST FREQUENTLY OCCURRING GRAM-POSITIVE BACTERIA. PSEUDOMONAS AERUGINOSA WAS THE MOST FREQUENTLY OCCURRING GRAM-NEGATIVE BACTERIUM. FUNGI (CANDIDA SPECIES) WERE SEEN IN 5 CASES IN THE WITHDRAWAL GROUP. FOR THE EMPIRICAL TREATMENT OF PERITONITIS, CEFAZOLIN SODIUM AND ISEPAMICIN SULFATE WERE USED PRIOR TO PD CATHETERIZATION. THEREAFTER, THE ANTIBIOTICS WERE DE-ESCALATED ACCORDING TO THE CULTURE RESULTS OR SWITCHED TO VANCOMYCIN HYDROCHLORIDE AND MEROPENEM HYDRATE IF THE SYMPTOMS WORSENED. ANTIBIOTICS WERE INTRAVENOUSLY ADMINISTERED AND CONTINUED FOR AT LEAST 2 WEEKS IN THE HOSPITAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
743534 PERITONEAL CATHETER CATHETER, PERITONEAL, LONG-TERM INDWELLING FJS COVIDIEN MFG SOLUTIONS S.A. PERITONEAL CATHETER

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R